![[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate structure](/static/products/141/1414360-71-6.png)
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
概要：[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate（CAS 1414360-71-6）是一种化学化合物，分子式为C28H34O3，分子量为418.25 g/mol。河南科弘生物科技有限公司提供CRO/CDMO定制合成服务，支持克级到吨级规格。
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
又称：[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
| 分子式 | C28H34O3 |
|---|---|
| 分子量 | 418.25 g/mol |
| LogP | 6.1435 |
| 拓扑极性表面积 | 43.37 Ų |
| 氢键供体数 | 0 |
| 氢键受体数 | 3 |
| 可旋转键数 | 2 |
| 精确质量 | 418.2508 |
| 重原子数 | 31 |
| 复杂度 | 957.7295 |
化学标识符
| CAS 编号 | 1414360-71-6 |
|---|---|
| SMILES | CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)C/C(=C\C5=CC=CC=C5)/C4=O)C)C |
产品概述
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate（CAS 1414360-71-6），分子式为C28H34O3，分子量为418.25 g/mol。IUPAC名：[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate。
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate化学性质概览
属性洞察：[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的XLogP值为6.1435，表明该化合物具有亲脂性（脂溶性好），可能影响其吸收、分布和配方策略。 [(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的拓扑极性表面积（TPSA）为43.37 Ų，极性较低，可能具有较好的细胞膜透过性。 根据Lipinski五规则，[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate有0个氢键供体和3个氢键受体，可能需要考虑配方优化。
常见问题
常见问题
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的CAS号是多少？
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的CAS号为1414360-71-6。
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的分子式是什么？
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的分子式为C28H34O3。
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的分子量是多少？
[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的分子量为418.25 g/mol。
在哪里可以购买[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate？
您可以直接向科弘生物询价[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate。联系我们或发送邮件至info@kehongbio.com获取报价和库存信息。
科弘生物是否提供[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate的定制合成服务？
是的，科弘生物提供[(3S,8R,9S,10R,13S,14S,16E)-16-benzylidene-10,13-dimethyl-17-oxo-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate及相关化合物的定制合成服务。请联系我们并告知您的具体需求，包括数量、纯度和交期。